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Developing Lymph Nodes Collect CD41CD32 LTb1
Cells That Can Differentiate to APC, NK Cells,
and Follicular Cells but Not T or B Cells
Reina E. Mebius,*‖ Paul Rennert,² lymph nodes in adult mice is different from the distribu-
tion in fetal and perinatal stages, when the first coloniza-and Irving L. Weissman³§
*Department of Cell Biology and Immunology tion of lymph nodes occurs (Mebius et al., 1996). MAd-
CAM-1 and a4b7 are the main adhesion molecules thatFaculty of Medicine
Vrije Universiteit direct the colonization of both PLN and MLN in late fetal
and early neonatal life. Beginning at 24±48 hr after birth,van der Boechorststraat 7
1081 BT Amsterdam PNAd expression begins on the luminal side of LN HEV,
allowing L-selectin±expressing cells in the bloodstreamThe Netherlands
²Biogen Incorporated to bind to and transmigrate through the endothelial cell
barrier in a L-selectin/PNAd±dependent fashion. BeforeCambridge, Massachusetts 02142
³Department of Pathology that time, cell traffic into the nodes is directed mainly by
the MAdCAM-1/a4b7 receptor/ligand pair, even though§Department of Developmental Biology
Stanford University School of Medicine the majority of nucleated blood cells are L-selectin posi-
tive (Mebius et al., 1996). Interestingly, cells expressingStanford, California 94305
a4b7 are infrequent in peripheral blood of fetal mice,
while the majority of the cells in the lymph nodes are
a4b71, suggesting a highly selective entrance mecha-Summary
nism for the first cells that colonize the lymph node,
although proliferation of these cells within the lymphFor a brief period during fetal lymph node organogene-
node cannot be excluded. One population of cells thatsis in mice, lymph node postcapillary high endothelial
express a4b7 and that enter lymph nodes before birthvenulessurprisingly express thePeyer's patch addressin
consists of CD41 cells that lack expression of CD3 (Meb-MAdCAM-1. This expression allows initial seeding of
ius et al., 1996), first described by Kelly and Scollaythis incipient structure by two unusual lymphocyte
(1992). The unusual phenotype of these cells demandedpopulations selectively expressing the Peyer's patch
their further characterization.homing receptor integrin a4b7: CD41CD32 oligoline-
age progenitors and TCR gd1 T cells. We show here
that CD41CD32 cells are lineage-restricted progeni- Results
tors that express surface lymphotoxin-b (LTb) and the
chemokine receptor BLR1 and that can become natu- CD41CD32 Cells Are a Unique Subset of Cells That
ral killer cells, dendritic antigen-presenting cells, and Express the Integrin a4b7 Homing Receptor and
follicular cells of unknown outcome, but these cells do That Arise in Fetal Spleen and Selectively
not become T or B lymphocytes. Since the necessity of Enter Fetal Lymph Node before Birth
lymphotoxin in lymphoid organ development has been We have observed an unexpected and exclusive expres-
shown, we propose that the novel subset of CD41 sion of MAdCAM-1 on HEV in PLN and MLN of fetal and
CD32LTb1 fetal cells is instrumental in the develop- newborn mice until 24 hr after birth. During this interval,
ment of lymphoid tissue architecture. a unique cell population of CD41CD32 cells enters the
lymph nodes using a4b7, a ligand for MAdCAM-1 (Meb-
Introduction ius et al., 1996). Since a specific adhesion mechanism
is in place for this cell population to colonize lymph
Lymphocyte homing to lymph nodes is mediated by a nodes, we chose to study these cells in more detail.
set of adhesion molecules expressed on endothelial At first, fetal peripheral blood was analyzed to deter-
cells (addressins) and their ligands (homing receptors) mine the frequency of these cells. To our surprise the
on lymphocytes. Lymphocytes in the bloodstream enter frequency of CD41CD32 cells in peripheral blood was
lymph nodes by adhering to and migrating through the low at all time points studied (14-, 15-, 17-, and 18-day-
high endothelial venules (HEV), specializedpostcapillary old fetuses) (Figure 1A). The peak in the percentage of
endothelial cells that express adhesion molecules (Gow- CD41CD32 cells in peripheral blood occurred at 15.5
ans and Knight, 1964; Kraal and Mebius, 1996). Because days postconception, but the total percentage of CD41
of differential expression of adhesion molecules on HEV CD32 cells inperipheral blood never exceeded 1%. Con-
in lymph nodes at different locationsÐnamely peripheral sidering the low percentage of CD41CD32 cells found
node addressin (PNAd) on HEV in peripheral lymph in peripheral blood it was surprising that more than 4%
nodes (PLN), and PNAd and MAdCAM-1 on HEV in mes- of MLN cells were CD41CD32 in 17.5-day-old embryos.
enteric lymph nodes (MLN)Ðlymphocytes are directed Since MLN isolated from day 16±18 embryos cannot
to different sites depending on their homing receptor be dissected completely free of surrounding tissue, the
expression profile. estimated percentage of CD41 cells measured by fluo-
The tissue distribution of these adhesion molecules rescence-activated cell sorting (FACS) could be low.
involved in directing the lymphocyte flow to different Indeed, sections of MLN taken from day 16 embryos
showed that approximately 30% of the cells expressed
CD4, while CD3 was absent.‖ To whom correspondence should be addressed (e-mail: r.mebius.
cell@med.vu.nl). To test whether CD41CD32 cells could also be found
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Figure 1. CD41CD32 Cells Can Be Found in
Fetal Peripheral Blood and Spleen but Not in
Fetal Liver
(A) Percentage of CD41CD32 cells in periph-
eral blood leukocyte preparations from 14-,
15-, 17-, and 18-day-old embryos and new-
born mice. The percentage of a4b7-express-
ing CD41CD32 cells in 14- and 15-day-old
embryos and in newborn mice was deter-
mined using MAb Datk-32, GK1.5, and 145±
2C11, recognizing a4b7, CD4, and CD3 re-
spectively.
(B) Analysis of fetal liver and fetal spleen from
14-day-old embryos for the presence of
CD41CD32 cells in combination with expres-
sion of a4. CD41CD32 cells could be detected
in fetal spleen, while no obvious population
of CD41CD32 cells could be observed in fetal
liver.
in other lymphoid organs, fetal spleen, liver, and thymus One early cellular event, described here, is the selec-
tive entry of CD41CD32 cells into the developing lymphwere analyzed. Analysis of fetal spleen showed that
nodes. Recently,multiple mutant mouse strains that lackCD41CD32 cells could also be found in fetal spleen
lymph nodes have been described. Null mutations of(E13.5±E17.5) with frequencies ranging from 0.2%±2.5%
lymphotoxin-a (LTa), LTb, RelB, and IL-2Rg chain allaround E14.5 (Figure 1B and data not shown). From fetal
result in lack of lymph nodes (Lo et al., 1992; Togni etdays 11 to 15.5, the liver is the principal repository of
al., 1994; Banks et al., 1995; Burkly et al., 1995; Cao et al.,multipotent hematopoietic stem cells (Morrison et al.,
1995; Weih et al., 1995; Eugster et al., 1996; Koni et al.,1995). FACS analysis of cells from E12.5 to E14.5 re-
1997). In addition, injection of LTb-R-Ig chimeras intovealed that CD41 cells were infrequent and attempts to
pregnant mothers results in lack of development of PLNsort CD41CD32 cells from fetal livers were unsuccessful
in newborn mice (Rennert et al., 1996). In addition, B(Figure 1B and data not shown). Thus, while it is likely
cell follicle formation also seems to involve signalingthat CD451CD41CD32 cells are derived from fetal liver
through the tumor necrosis factor (TNF) and LTb recep-hematopoietic stem cells, if they are, this phenotype
tor (Pasparakis et al., 1996; Rennert et al., 1997). Themust be induced in secondary sites (such as the fetal
cellular and molecular events that are involved in thespleen). We then tested whether the thymus, the other
formation of lymph nodes and follicles have not beenmajor lymphopoietic organ at 12±17 days postconcep-
defined.tion, harbored the cells. Analysis of the fetal thymus
Could early colonization of LN by CD41CD32 cells befor CD41CD32 cells revealed that this population was
involved in the formation of lymph nodes or follicles?undetectable. Thus CD41CD32 a4b71 cells are first
Analysis of CD41CD32 cells for expression of LTb,found in early (13.5 days postconception) fetal spleens.
RelB, or IL-2Rg chain was performed. FACS analysis
of CD41CD32 cells, using an LTb-R-Ig fusion protein,
Newborn Lymph Node CD41CD32 Cells Are showed expression of LTb on CD41CD32 in MLN at
Lymphotoxin-b1 and Express Lymphoid E18.5 (Figure 2A). Subsequently, CD41CD32 cells from
Cytokine Receptors MLN, taken within 6 hr after birth, were sorted into lysis
CD41CD32 cells belong to the hematolymphoid line- buffer and reverse-transcribed to obtain cDNA. Analysis
ages since the leukocyte common antigen CD45 (Ly5) of cDNA with specific primers for relB and LTb showed
was uniformly expressed on CD41CD32 cells (Table 1). both bands of the appropriate size, which could be am-
FACS analysis of newborn CD41CD32 cells derived from plified with one internal primer for each band (Figure
lymph nodes showed that the cells express ICAM-1, 2B). In addition, we also observed expression of IL-2Rg
CD44, and IL-7Ra at high levels, while about 75% of the chain on CD41CD32 cells (Figure 2C).
cells express the IL-2Ra chain (CD25) (Table 1). Staining CD41CD32LTb1IL-2Rg1 cells, derived from MLN at
for the common g chain of the IL-2 receptor (IL-2Rgc) birth, are negative for the natural killer (NK)± specific
showed that all CD41CD32 cells express this subunit antigens NK1.1 (Koo and Peppard, 1984; Yokoyama and
common to the IL-2, IL24, IL27, IL-9, and IL215 recep- Seaman, 1993) and 2B4 (Garni-Wagner et al., 1993) (Ta-
ble 1). Staining in situ for the dendritic cell markerstor (Table 1).
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in C57BL/KA-Thy1.1 and C57BL/KA-Thy1.2 mice, re-Table 1. Phenotypic Characterization of CD41 CD32 Cells
Isolated from MLN on Day 0 spectively. In C57BL/KA-Thy1.1 mice the expression of
Thy1.1 on CD41CD32 cells was high, while the expres-Surface Antigen Expression
sion of Thy1.2 on these cells from Thy1.2 mice was low
ICAM-1 1 to medium (Table 1) (In these two congenic lines, the
CD44 1
same relative differential expression of Thy1 is also
a4 1
found on adult bone marrow hematopoietic stem cellsb7 1
[Spangrude and Brooks, 1992]).a4b7 1
L-selectin 2 Subsequently, newborn nude mice were analyzed to
MHC class I 1 test whether the dysplastic thymus could affect the
MHC class II 1(650%) number of CD41CD32 cells that could be found in lymph
TCR ab 2
nodes. In MLN of control, heterozygous, and homozy-TCR gd 2
gous nude mice, we observed CD41CD32 cells in com-CD3 2
parable numbers, suggesting that the existence ofCD5 2
sIgM 2 CD41CD32 cells is thymus independent.
B220 2 To examine more exhaustively the possibility that
Ly5 1 CD41CD32 cells belong to the T lymphocyte lineage,
Thy1.1 1
the configuration of the TCR was analyzed. Since re-Thy1.2 Low to medium
arrangement of the b chain of the TCR precedes re-IL-2R 1(675%)
arrangement of the a chain, we used primers to deter-IL-7R 1
IL-2Rgc 1 mine whether Db1.1 to Jb1.7 or Db2.1 to Jb2.7 were
Sca-1 2 rearranged. CD41CD32 cells from newborn MLN were
c-Kit 2 to low sorted into lysis buffer and genomic DNA was analyzed
Mac-1 2
by polymerase chain reaction (PCR). Figure 3A showsGr-1 2
that the TCR genes of CD41CD32 cells are in germlineNLDC-145 2
configuration when analyzed for rearrangement fromCD11c 2
B7-1 2 Db1.1 to Jb1.7 and Db2.1 to Jb2.7, while control CD81
B7-2 2 thymocytes show rearrangement of the TCR b chain
CD40 2 (Figure 3A). In addition, analysis of cDNA derived from
NK1.1 2 sorted CD41CD32 cells showed no expression of theFcgRIII/II Low to medium
pre-T cell receptor-a (pTa) when analyzed by PCR withCR1/CR2 2
seminested primers (data not shown).
To analyze the potential of CD41CD32 cells as precur-
sors to T lymphocytes, CD41CD32 cells were placed in
NLDC-145 and N418, recognizing DEC-205 and CD11c a fetal thymic organ culture (FTOC). After culturing the
(integrin p150a) respectively (Kraal et al., 1986; Metlay cells for 2 weeks in irradiated Rag22/2 thymic lobes, no
et al., 1990), showed that CD41CD32 cells lack expres- maturation toward the T lymphocyte lineage could be
sion of both markers. No accessory molecules, such as observed (data not shown).
B7-1, B7-2, or CD40 could be observed at normal levels
of expression at this stage of development.All CD41 CD32
cells lack expression of CD5. Staining with monoclonal CD41CD32 Cells Are Neither B Cells nor Precursors
antibody (MAb) 2.4G2, recognizing FcgRIII/II (CD16/32), to the B Lymphocyte Lineage
showed expression of this receptor on CD41CD32 cells. Our results suggest that CD41CD32 cells do not belong
No expression of CR1/CR2 could be detected. to the T lymphocyte lineage since the TCR genes are in
To study whether CD41CD32 cells expressed mark- germline configuration, no expression of pTa can be
ers of more primitive hematolymphoid progenitors, we detected, and CD41CD32 cells do not develop toward
tested for the presence of Sca-1 and c-Kit. These mark- the T lymphocyte lineage when placed in an FTOC. The
ers have been described to bepresent on hematopoietic question arises: do they belong to the class of lympho-
stem cells and T cell progenitors (Spangrude et al., 1991; cytes that rearrange and express antigen receptors at
Akashi and Weissman, 1996; Randall et al., 1996). CD41 all? CD41CD32 cells were analyzed for characteristics
CD32 cells do not express Sca-1 and show low, if any, of B lymphocytes. Staining of CD41CD32 cells, derived
expression of c-Kit (Table 1). from MLN taken from newborn mice within 24 hr after
birth for B220 and sIgM, showed that all CD41CD32
cells are negative for both (Table 1). In addition, analysisCD41CD32 Cells Are Neither T Lymphocytes
nor T Lymphocyte Precursors of genomic DNA from CD41CD32 cells with primers to
analyze IgH chain genes showed that genes for the IgHCD41CD32 cells lack expression of CD3, while mature
T lymphocytes normally express CD3 proteins as part of chain are in germline configuration, while B cells show
rearranged bands (Figure 3B). As a negative control, Tthe T cell receptor complex. To test whether CD41CD32
cells are T lymphocytes, CD41CD32 cells from MLN of cells were analyzed: sorted T cells were resorted twice
to ensure purity. In this population we observe the genesnewborn mice were stained for T cell receptor (TCR)
ab, TCR gd, and Thy1. Stainings for TCR showed no for IgH chain in germline arrangement and some re-
arranged bands, a phenomenon previously describedexpression of TCR ab or TCR gd (Table 1). To study
Thy1 expression, we analyzed both Thy1.1 and Thy1.2 for T cells (Kurosawa et al., 1981).
Immunity
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Figure 2. CD41CD32 Cells Express LTb, RelB,
and IL-2Rgc
(A) Staining of CD41CD32 cells for surface
expression of LTb using murine LTb-R-Ig. As
a negative control, cells were incubated with
LFA-3-Ig or LTb-R-Ig in the presence of anti-
LTb MAb (BBF6).MLN were isolated from em-
bryos at 18.5 days of gestation (E18.5). At
this time point no CD41CD31 cells could be
observed, and when double staining for CD4
and LTb-R-Ig was performed, all CD41 cells
showed low to medium staining with LTb-R-
Ig but no staining with LFA-3-Ig or LTb-R-Ig
in the presence of blocking anti-LTb MAb.
(B) Analysis of cDNA from CD41CD32 cells
isolated from MLN on day 0 for LTb and relB
by RT-PCR showed that bands for both LTb
as well as relB could be observed when semi-
nested primers were used.
(C) Staining of CD41CD32 cells, taken from
MLN on the day of birth, for IL-2Rgc showed
that all CD41CD32 cells were positive.
To test ultimately whether CD41CD32 cells had no in the presence of IL-2. At the population level, the cells
showed morphological characteristics of activation andprogenitor±progeny relation to B lymphocytes, we placed
sorted CD41CD32 cells on S17 stromal cells in the pres- proliferated (Figure 4A). To assess the frequency of
CD41CD32 cells that are responsive to IL-2, CD41CD32ence of IL-7. Although the bone marrow cells gave B cell
colonies at a frequency of 0.1%, no maturation toward B cells were double sorted and single cells were deposited
into separate wells of 96-well plates. The cells were cul-cell lineage could be observed for CD41CD32 cells.
To test whether CD41CD32 cells belong to the rear- tured in IL-2, on AC-6.2.1 feeder layers, and were ana-
lyzed for clonal expansion. After approximately 10 days,ranging antigen receptor lymphocyte class, we analyzed
the presence of mRNA for recombinase genes Rag1 outgrowth of cells was obvious and the frequency of
IL-2±responding cells was determined. Approximatelyand Rag2by reverse transcription (RT)±PCR. CD41CD32
cells, derived from MLN of newborn mice, were sorted 10%±20% of the wells showed clonal expansion of cells,
varying among experiments. Further analysis of theinto lysis buffer and reverse transcribed for the produc-
tion of cDNA. PCR reactions with primers specific for clones showed that 680% of them expressed NK1.1,
and all NK1.1-expressing clones were able to kill YAC-Rag1 and Rag2 showed that CD41CD32 cells do not
have mRNA for these two recombinase genes (Figure 1 cells in the presence of concanavalin A (Figure 4B).
Since NK1.1 is not expressed on CD41CD32 cells when3C). Analysis of Rag22/2 and severe combined immuno-
deficient (SCID) mice revealed a diminished but dis- analyzed directly after isolation from newborn lymph
nodes, and freshly isolated CD41CD32 cells lack thetinguishable population of CD41CD32 cells (data not
shown; see also Figure 6B, below). Therefore it is possi- ability to kill YAC-1 cells, differentiation of CD41CD32
progenitors into NK cells must have occurred (Fig-ble that lymphogenesis might affect the genesis and/or
maintenance of CD41CD32 cells. ure 4C).
CD41CD32 Cells Can Be Cultured in IL-2
and Generate NK1.11 NK Cells CD41CD32 Cells Contain APC Precursors
When CD41CD32 newborn MLN cells were stained forSince the majority of CD41CD32 cells express CD25
(IL-2Ra) and the IL-2Rgc chain, CD41CD32 cells could expression of I-A or I-E, approximately 50% of the cells
showed expression of class II (Figure 5A). To testpotentially proliferate and differentiate in response to
IL-2. CD41CD32 cells from MLN, taken from newborn whether CD41CD32 cells are precursors for macro-
phages or dendritic cells, we plated a sorted populationmice within 24 hr after birth, were sorted and cultured
CD41CD32 Precursor Cells in Neonatal Lymph Nodes
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from MLN within 24 hr after birth express MHC class II
molecules, we were interested to determine whether
CD41CD32 cells could present antigen. CD41CD32 cells
were sorted from MLN within 24 hr after birth and cul-
tured overnight with the pigeon cytochrome C±specific
T cell hybridoma 2B4 (Hedrick et al., 1982) in the pres-
ence and absence of cytochrome C.As a positive control
for antigen presentation, a lipopolysaccharide-activated
B cell line was used. After 18 hr of culture, the superna-
tants were analyzed for the presence of IL-2 as a mea-
sure of the activation of 2B4 cells by cytochrome C on
class II±positive cells. Production of IL-2 by 2B4 cells
could be induced by CD41CD32 cells in the presence
of cytochrome C. However, on a cell-to-cell basis the
induction of IL-2 production by CD41CD32 cells was
much lower when compared to lipopolysaccharide-
stimulated B cells (data not shown).
To test whether CD41CD32 cells could further differ-
entiate into antigen-presenting cells (APC), we cultured
the cells overnight in the presence of IL-4 and GM-CSF
(Sallusto and Lanzavecchia, 1994) and subsequently
placed the cells as effector cells in an allogeneic mixed
lymphocyte reaction (MLR). As a control, CD41CD32
cells cultured overnight in medium alone and CD42 cells
cultured with and without IL-4 and GM-CSF were used.
As a positive control, dendritic cells isolated from PLN
Figure 3. CD41CD32 Cells Rearrange Neither the TCR b chain nor were used. CD41CD32 cells cultured overnight in IL-4
the IgH Chain, and They Do Not Contain mRNA Coding for the
and GM-CSF were as potent in inducing allogeneic TRecombinase Enzymes RAG1 and RAG2
lymphocytes to proliferate as were purified dendritic
(A) Characterization of CD41CD32 cells as potential members of the
cells (Figure 5B). CD41CD32 cells cultured in mediumT lymphocyte lineage. Analysis of the b chain of the TCR in genomic
alone and CD42 cells were not able to induce allogeneicDNA isolated from triple-sorted CD41CD32 cells showed no re-
arrangements but germline configuration of the gene. As a positive T lymphocytes to proliferate (Figure 5B). Thus, CD41
control, CD81 cells were sorted from the thymus, and as a negative CD32 cells contain potent progenitors of dendritic APC.
control, B lymphocytes were sorted from adult MLN. During the course of our studies it was reported that
(B) Characterization of CD41CD32 cells as potential B lymphocyte thymic precursors, isolated from mature thymus, were
lineage members. Genomic DNA isolated from triple-sorted CD41
induced to proliferate and differentiate to dendritic cellsCD32 cells showed no rearrangement of the IgH chain genes. As a
when grown in the presence of a different mixture ofpositive control, B lymphocytes sorted from adult MLN were used
and CD81CD31CD42 cells sorted from the thymus were used as a five to seven cytokines (Saunders et al., 1996). Since in
control for germline configuration. these studies GM-CSFwas not necessary for differentia-
(C) Analysis of cDNA from CD41CD32 cells isolated from MLN on tion, we tested whether CD41CD32 cells could also dif-
day 0 and 8 weeks after birth and from bone marrow at 8 weeks ferentiate into dendritic APC in the absence of GM-CSF.
after birth for the presence of mRNA coding for the recombinase
We therefore cultured the cells in IL-1b, IL-3, IL-7, andenzymes RAG1 and RAG2. In all CD41CD32 samples cDNA for Rag1
TNFa. This mixture of cytokines induced proliferation ofand Rag2 could not be found by RT-PCR. As a positive control, a
B cell lymphoma, BCL2-3, was used (Chen et al., 1994). CD41CD32 cells and cluster formation characteristic for
dendritic cells as described (Saunders et al.,1996). How-
ever, after 5 days of culture, 10% of the cells were found
of CD41CD32 cells, derived from MLN, in methylcel- to express low levels of MHC class II, while the remaining
lulose in the presence of granulocyte-macrophage 90% were negative, in contrast with theCD4lo precursors
colony-stimulating factor (GM-CSF), according to the found in the thymus (Saunders et al., 1996). The class
method described by Inaba et al. (Inaba et al., 1993). As of cells that develop in this cytokine mixture needs to
a positive control, we sorted major histocompatibility be determined.
(MHC) class II±negative precursors from bone marrow
that can give rise to macrophages and dendritic cells
when grown in semisolid culture in the presence of GM- CD41CD32 Cells Can Be Found in B Cell Areas
To determine the location of CD41CD32 cells within theCSF (Inaba et al., 1993). After a culture period of 14
days, we observed multiple colonies in our positive bone lymph nodes, cryostat sections of newborn MLN and
PLN were stained for CD3 and CD4. In lymph nodesmarrow control, but no colonies in the cultures of
CD41CD32 cells in GM-CSF. Even after prolonged cul- taken within 24 hr after birth, CD41CD32 cells could be
found throughout the lymph nodes. At this time very fewture periods no colonies from CD41CD32 cells could be
observed, suggesting that the CD41CD32 population T cells are present in the lymph nodes and distinct B
and T cell areas are absent (Friedberg and Weissman,does not contain clonal activity for macrophages or den-
dritic cells inducible by GM-CSF alone (data not shown). 1974; R.E.M., unpublished data). Upon staining of the
lymph node sections at 2, 3, and 4 days after birth withSince approximately 50% of CD41CD32 cells taken
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Figure 4. CD41CD32 Cells Can Proliferate in
the Presence of IL-2 and Differentiate into NK
Cells, While Freshly Isolated CD41CD32 Cells
Do Not Express NK Cell±Specific Antigens
(A) Overnight culture of bulk-sorted CD41
CD32 cells in the presence of IL-2 (250 U/ml)
showed that CD41CD32 cells responded well
to this cytokine.
(B) Culture of CD41CD32 cells in IL-2 on AC-
6.2.1 feeder layers. CD41CD32 cells were
sorted twice and deposited at a single cell/
well in a 96-well plate containg AC-6.2.1
feeder layers and IL-2 (250 U/ml). Within 10
days growth could be observed in 10%±20%
of the wells, varying among experiments. The
colonies were analyzed for NK surface mark-
ers by staining with MAb NK1.1 and 2B4 and
their ability to kill YAC-1 cells in the presence
of concanavalin A. Cells derived from NK1.11
colonies could kill 100% of the target cells at
a E:T ratio of 20, while lack of NK1.1 surface
molecule coincided with less efficient killing
of the target cells. Eighty percent of the colo-
nies that grew out in the presence of IL-2
expressed NK1.1.
(C) Analysis of freshly isolated CD41CD32
cells for the expressionof NK surface markers
by staining with MAb NK1.1 and 2B4 show
that CD41CD32 cells lack expression of NK
surface markers when taken directly from
MLN on day 0.
MAb 6B2, recognizing B220 (Coffman and Weissman, numbers in neonatal lymph nodes (Kelly and Scollay,
1992; Mebius et al., 1996). Our results show that1981), B cell follicles could easily be distinguished at 4
days after birth. At 2 days after birth the distinction CD41CD32 cells demonstrate uniform expression of
CD45, and thus belong to the hematopoietic system andbetween B and T cell areas became obvious. Lymph
node sections of 2-day-old animals analyzed for CD41 form a newly described subset of hematolymphoid cells.
CD41CD32 cells enter the lymph nodes during fetal lifeCD32 cells revealed CD41CD32 cells in the cortical area,
where B cell follicles were then starting to form (Figure and 0±1 days after birth, using the Peyer's patch homing
receptor, integrin a4b7 on their surface, and its ligand6A). When PLN from SCID mice were analyzed at 10
days after birth, CD41CD32 cells had accumulated in MAdCAM-1 on the opposing HEV (Mebius et al., 1996).
The population contains NK cell precursors and den-the cortical area of the lymph nodes (Figure 6B). That
CD41CD32 cellsspecifically migrate to theB cell follicles dritic APC precursors, and most cells tend to localize
in B cell follicles.could further be confirmed in transfer studies. Ly5.2±
expressing CD41CD32 cells, isolated from lymph nodes Further characterization of CD41CD32 cells shows
that they rearrange neither the b chain of the TCR norof newborn mice, were transferred into C57BL6/Ly5.1
hosts on the day of birth. At 8 days after transfer, Ly5.21 the IgH chain, that they do not express pTa, and that
they lack mRNA for the recombinase enzymes RAG1 anddonor cells were always found in B cell follicles, sur-
rounded by FDC-M21 cells (Figures 6C and 6D). RAG2, suggesting that CD41CD32 cells do not belong to
Recently, the chemokine receptor BLR1 has been the T or B lymphocyte±rearranging subset of hemato-
shown to play a role in B cell migration to the follicles lymphoid cells. That CD41CD32 cells do not belong to
(Forster et al., 1996), where we also observe relatively the B lymphocyte lineage is further supported by their
high numbers of CD41CD32 cells and where we find the inability to differentiate into B220-expressing B cells in
cells after transfer. Therefore, cDNA derived from sorted IL-7±containing S17 cultures. That CD41CD32 cells do
CD41CD32 cells was analyzed for expression of Blr1 by not belong to the T lymphocyte lineage is further sub-
seminested PCR. As expected from our transfer studies, stantiated by the presence of CD41CD32 cells in neona-
we observed Blr1 expression in all lymph node CD41 tal lymph nodes from nude, Rag22/2, and SCID mice
CD32 cDNA samples tested (Figure 7). and by their inability to differentiate into T lymphocytes
when placed in FTOC, as shown for CD41CD32 cells
Discussion isolated from human peripheral blood (Bruno et al.,
1997). However, human CD41CD32 cells present in pe-
ripheral blood express pTa and low levels of CD3-e andA cell population characterized by uniform expression
of CD4 and lack of CD3 can be found at relative high have initiated rearrangements of the TCR b chainÐall
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Figure 5. Fifty Percent of CD41CD32 Cells
Express MHC Class II, and Overnight Culture
in IL-4 and GM-CSF InducesCD41CD32 Cells
to Become Potent APC
(A) Analysis of newborn CD41CD32 cells for
the expression of MHC class II molecules
showed that approximately 50% of the cells
expressed I-Ak or I-Ek.
(B) CD41CD32 cells were cultured overnight
in the presence of IL-4 and GM-CSF. As a
control, CD41CD32 cells were cultured over-
night with media alone (no growth factor).
Also, all cells from MLN except CD41CD32
cells were exposed to the same culture con-
ditions (with or without IL-4 and GM-CSF).
The cells were subsequently mixed with 105
allogeneic T lymphocytes. As a positive con-
trol, purified dendritic cells, isolated from PLN
and MLN, were mixed with the same number
of T lymphocytes, and as a negative control,
T cells or dendritic cells alone were placed
in a well. After 4 days [3H]thymidine (1 mCu/
well) was added, and after 6 hr the incorpora-
tion of [3H]thymidine was measured, showing
that CD41CD32 cells cultured overnight in
IL-4 and GM-CSF are as potent in inducing an
allogeneic MLR as are dendritic cells isolated
from lymph nodes.
features absent in the cells described here (Bruno et al., these cells are isolated from fetal thymus. The low ex-
pression level of CD4 on these precursors and the in-1997).
CD41CD32 cells could not be found in the fetal liver ability to find these cells in fetal and newborn animals
(Antica et al., 1993) suggest that this precursor popula-or thymus between days E12.5 and E15.5. The popula-
tion was present in the spleen, as early as the spleen tion resembles one unrelated to the CD41CD32 cells
described here. Another population of early fetal thymo-could be isolated (E13.5), suggesting that the fetal
spleen could be the site of their development. How- cytes, which can give rise to T lymphocytes and NK
cells, has been described (Rodewald et al., 1992). Al-ever, analysis of neonatal lymph nodes from spleenless
Hox112/2 mice shows that CD41CD32 cells are present; though this population has similarities to the CD41CD32
cells described here, such as expression of FcgRIII/II,thus, the spleen per se is not mandatory for their devel-
opment (data not shown). Another place of origin could IL-2Ra, and Thy1 and maturation into NK cells in re-
sponse to IL-2, expression of CD4 is absent on thesebe the aorta-gonad-mesonephros region, which has re-
cently been identified as a preliver intraembryonic site cells (Rodewald et al., 1992).
Immunohistological stainings of fetal and neonatalthat harbors precursors of adult type hematopoietic
stem cells (Medvinsky and Dzierzak, 1996; Medvinsky lymph nodes show that CD41CD32 cells are scattered
throughout the lymph nodes until 2 days after birth,et al., 1993; MuÈ ller et al., 1994).
The observed activities for NK cells and APC within when they tend to localize in the cortical area of the
lymph node. This localization can be observed in theone cell population are noteworthy, since a common
human lymphoid precursor that gives rise to T and B absence or presence of classic B and T lymphocytes,
suggesting that the localization of CD41CD32 cells doeslymphocytes, NK cells, and dendritic cells has been de-
scribed (Galy et al.,1995), as has a mouse cellpopulation not depend on the presence of rearranging lympho-
cytes. Expression of the putative chemokine receptorwith the same potentials (Wu et al., 1991; Wu et al., 1996;
Kondo et al., unpublished data). From adult thymus, a BLR1, directing B cell migration to splenic follicles, can
be detected in CD41CD32 cells, suggesting a role forprecursor population, with low expression levels of CD4,
that has the ability to generate dendritic, B, T lymphoid, BLR1 in the positioning of CD41CD32 cells in thecortical
area. This is further supported by our transfer studies,and NK cells, can be isolated (Wu et al., 1991, 1996;
Ardavin et al., 1993; Matsuzaki et al., 1993; Saunders et in which we always found the donor cells localized in
the B cell follicles. This localization of CD41CD32 cellsal., 1996). However, this activity cannot be seen when
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Figure 6. CD41CD32 Cells Can Be Found in
the Cortical Area of Developing Lymph Nodes
and Localize in B Cell Follicles upon In Vivo
Transfer
(A) Double staining of PLN from 2-day-old
mice for CD4 (rhodamine) and CD3 (fluores-
cein isothiocyanate). With the combination of
red and green all CD41CD32 cells are red,
while CD41CD31 cells are yellow. At this time
point B and T cell areas in PLN can be distin-
guished. Most CD41CD32 cells can be found
in the cortical area of the lymph nodes.
(B) Double staining of PLN from 10-day-old
SCID mice for CD4 (rhodamine) and CD3
(fluorescein isothiocyanate). All the CD41
CD32 cells line up in the cortical area.
(C and D) Double staining of day 8 lymph
node derived from a C57BL6/Ly5.1 mouse
that received 2000 sorted CD41CD32 cells
(derived from C57BL/Ka (Ly5.2) mouse) intra-
venously on the day of birth for donor marker
Ly5.2 (C) and in the same section for FDC-
M2 (D). The Ly5.2 donor cell can be found
among the FDC-M2±expressing cells in the
primary follicles.
around the time that follicles are being formed, before are similar to these CD41CD11c1CD32 dendritic cells
(GCDCs) in the expression of markers such as CD44,follicular dendritic cells (FDC) can be detected, is sug-
gestive of a third progenitor activity for CD41CD32 cells CD45, and ICAM-1, and lack of CD3, TCRab, TCRgd,
B7-1, and B7-2 (Grouard et al., 1996). The localizationas FDC precursors. However, FDC are MAdCAM-11,
and these precursors express the MAdCAM-1 ligand of GCDCs in germinal centers and CD41CD32 cells in
B cell follicles suggests that these subsets could beintegrin a4b7 (Berlin et al., 1993; Szabo et al., 1997;
R. E. M., unpublished data). Previous experiments have related. However, CD41CD32 cells lack expression of
CD11c, one of the three antigensused to identify GCDCsindicated that in adult radiation chimeras, FDC are not
bone marrow derived, which has led to the conventional (Grouard et al., 1996). In addition, the ultrastructural
characteristics of CD41CD32 cells are very similar towisdom that they are stromal elements independent of
hematopoietic lineages (Humphrey et al., 1984). How- early precursors, while GCDCs have characteristics of
dendritic cells (Grouard et al., 1996; data not shown).ever, if FDC precursors are produced only from hemato-
poietic precursors in late fetal/early neonatal life, and if The observation that CD41CD32 cells become strong
inducers of an allogeneic reaction afterovernight culturethey use the integrin a4b7/MAdCAM-1 adhesion pair to
enter neonatal lymph nodes, adult radiation chimeras in IL-4 and GM-CSF, while GCDCs can induce strong
proliferation of allogeneic T cells without prior culture,could not test whether they are derived from hematopoi-
etic stem cells. Because FDC are CD452 (Ly52) (Schriever supports the idea that the CD41CD32 cell population
could contain precursors to GCDCs.et al., 1991), we cannot use Ly5 congenic pairs to test
the hypothesis that FDC are also derived from CD41 CD41CD32 cells show surface expression of LTb and
IL-2Rgc, and at the mRNA level, using RT-PCR, containCD32 cells. At this point we can only surmise that CD41
CD32 cells are FDC precursors or cells that aid in the message for LTb, relB, and Blr1. It is noteworthy that a
cell population that is relatively abundant in the devel-development of FDC.
Another cell population with dendritic morphology oping lymph nodes expresses four markers (LTb, RelB,
gc receptor, and BLR1) involved in the formation ofpresent in germinal centers has been described recently
(Grouard et al., 1996). These cells are defined by expres- lymphoid tissue architecture. Blocking of LTb by in utero
injections of LTb-R-Ig, and null mutation of LTa, LTb,sion of CD4 and CD11c and lack of CD3 expression
(Grouard et al., 1996). CD41CD32 cells, described here, IL-2Rgc, and RelB all result in the absence of at least
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lack of expression of many surface markers, except
IL-2R and MHC class II, which seem to dividethe popula-
tion. We observed the following activities within the
CD41CD32 population: in response to IL-2, a fraction of
CD41CD32 cells turn into NK cells; in reponse to IL-4
and GM-CSF, CD41CD32 cells differentiate into APC;
and in response to IL-1b, IL-3, IL-7, and TNFa, CD41
CD32 cells proliferate. Our hypothesis that CD41 CD32
cells play a role in the initiation of lymph nodes is sup-
ported by several observations: expression of LTb,RelB,
IL-2Rgc, and BLR1, all involved in the formation of the
lymph nodes; the early appearance of CD41CD32 cells
in beginning lymph nodes; and the selective expression
of MAdCAM-1 on HEV, allowing CD41CD32 cells to ac-




C57BL/KA-Thy1.1, C57BL/KA-Thy1.2, BALB/c, and AKR mice were
Figure 7. CD41CD32 Cells Contain mRNA for the Putative Chemo- maintained in the laboratory animal colony at Stanford University
kine Receptor BLR1 School of Medicine.
Analysis of cDNA from CD41CD32 cells isolated from MLN on day
0 and 8 weeks after birth and from bone marrow at 8 weeks after Antibodies and Staining
The following antibodies and reagents were used for staining: GK1.5birth for the presence of mRNA coding for the putative chemokine
receptor BLR1. In all CD41CD32 samples from lymph nodes, cDNA (anti-CD4); 145-2C11 (anti-CD3); KT-31 (anti-CD3); 3A10 (anti-gd-
TCR); H57-597 (anti-ab-TCR), 3E2 (anti-ICAM-1); IM781 (anti-CD44);for Blr1 could be found by RT-PCR. However, CD41CD32 cells
sorted from bone marrow lacked mRNA for Blr1. As a positive con- R1-2 (anti-a4); M298 (anti-b7); Datk-32 (anti-a4b7); Mel-14 (anti-
L-selectin); 53-7.3 (anti-CD5); AF6-88.5 (anti-H-2Kb); 30-H12 (anti-trol, two different lymphomas were used: 38C13 and TK-1 (Butcher
et al., 1980; Gallatin et al., 1983). Thy1.2); 7D4 (anti-IL-2Ra, CD25); 2.4G2 (anti- FcgIII/IIR, CD16/32);
NLDC-145 (anti-DEC205); 6B2 (anti-B220); M1/70 (anti-Mac-1); 8C5
(anti-Gr-1); AL1-4A2 (anti-Ly5.1); 2B8 (anti-c-Kit, CD117); 19XE5
(anti-Thy1.1); TUGm3 (anti-IL-2 receptor g chain) (Kondo et al., 1993,PLN and a disorganized spleen that lacks B cell follicles
1994); A7R34 (anti-IL-7 receptor) (Sudo et al., 1993); E13 (anti-Sca-(Lo et al., 1992; Togni et al., 1994; Banks et al., 1995;
1); 11-5.2 (anti-I-Ak) (Pharmingen); 14-4-4S (anti-I-Eb) (Pharmingen);Burkly et al., 1995; Cao et al., 1995; Weih et al., 1995;
NK1.1 (anti-NK cell marker) (Pharmingen); N418 (anti-CD11c); 1G10
Eugster et al., 1996; Koni et al., 1997). Blocking of BLR1 (anti-B7-1) (Pharmingen); GL1 (anti-B7-2) (Pharmingen); 1C10 (anti-
inhibits the maturation of B cell follicles (Forster et al., CD40); 7G6 (anti-CR1/CR2) (Pharmingen); mouse LTRb fused to
1996). We propose that CD41CD32 cells play a role in human IgG1 (Browning et al., 1997). Stained cells were analyzed
using a dual laser FACS (Becton Dickinson Immunocytometry Sys-the initiation of lymphoid structures during ontogeny.
tems, Mountain View, CA), gating out dead cells and debris andOf interest is the independent observation that inPeyer's
sometimes blocking the CD16/32 FcR with MAb 2.4G2. Immunohis-patch development, expression of CD4 in the absence
tochemistry was carried out as described previously (Mebius et al.,
of CD3 can be observed, while simultaneously the ex- 1991).
pression of IL-7R is present in these early structures,
suggesting that CD41CD32IL-7R1 cells in the devel- Preparation of Genomic DNA and cDNA for PCR Analysis
oping Peyer's patch and LN are similar (Spencer et al., Genomic DNA of sorted cell populations was prepared by sorting
approximately 800 cells directly into 10 ml 13 PCR buffer containing1986; Adachi et al., 1997). To test whether there indeed
0.5% Tween 20 and 100 mg/ml proteinase K and then placing themis a role for CD41CD32 cells in the formation of lymph
for 40 min at 568C followed by 10 min at 948C to inactivate pro-nodes, CD41CD32 cells need to be specifically elimi-
teinase K.
nated, perhaps genetically, by virtue of CD4 expression cDNA was generated from cell populations sorted directly into
and lack of CD3 expression. We have yet not found RT reaction buffer as described (Chang et al., 1991). A maximum
a mutant mouse strain that lacks CD41CD32 cells in of 1000 cells were deposited in 20 ml of RT/lysis buffer and cDNA
prepared.developing lymph nodes, even in the smallest lymph
nodes that we have analyzed. Our hypothesis would be
PCR Analysisthat CD41CD32 cells provide accessory cells in lym-
Genomic DNA was analyzed for rearrangement of the b chain of thephoid structures, necessary to form lymph nodes or
TCR or the IgH chain by amplifying 0.2 ml of the first PCR reaction
lymphoid tissue architecture. It will be important to see with internal primers. Per reaction, 0.5 mM of each primer, 0.4 mM of
whether CD41CD32 cells are also involved in autoim- each dNTP, 1.5 mM MgCl2, and 0.5 U of Taq polymerase (Boehringer
Mannheim) were used. The first amplification cycle (30 s/2 min/mune and chronic inflammatorydiseases in which lymph
3 min at 948C/638C/728C, respectively) was repeated nine times,node±like structures are formed in extralymphatic tis-
followed by 25 cycles (30 s/1 min/3 min at 948C/638C/728C, respec-sues (Pozzilli et al., 1993; Kratz et al., 1996).
tively).In summary, we have described a novel subset of the
cDNA was analyzed for the presence of Rag1, Rag2, LTb, Blr1,
hematopoietic lineage. The population is characterized and relB. For LTb, Blr1, and relB, 1 ml of the first PCR reaction was
by expression of CD4 and LTb and lack of CD3. The amplified with one internal 59 primer in combination with the same
39 primer to ensure specificity. For relB, Blr1, and LTb primers,population demonstrates homogeneous expression or
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the amplification cycles were identical to the ones used with the National Cancer Institute grant CA42551 (to I. L. W.), the Arthritis
Foundation (R. E. M.), and the Royal Netherlands Academy of Artsrearrangement primers (Tanneal: relB, 638C; LTb, 578C; and Blr1, 588C).
For Rag1 and Rag2 primers, the first amplification cycle (30 s/30 and Sciences (R. E. M.).
s/45 s at 948C/628C/728C, respectively) was repeated four times and
followed by 21 amplification cycles at a lower annealing temperature
Received July 21, 1997; revised September 8, 1997.(30 s/30 s/45 s at 948C/588C/728C, respectively).
The following oligonucleotides were used for PCR:
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